No profile data available.
InMode Ltd. (INMD) is a healthcare company in the additional specific healthcare equipment industry, based in Yokne'am, Israel, with about 660 full-time employees.
It reported revenue of $370.50 million for fiscal year 2025, down 6.2% from fiscal year 2024, and net income of $93.83 million. United States was its largest region in fiscal year 2025, with 54% of revenue. Its market capitalization was $817.70 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
InMode reported $370.50 million in revenue for fiscal year 2025, down 6.2% from $394.82 million in fiscal year 2024.
United States: 54% of revenue by region in fiscal year 2025, followed by Europe (21%).
$817.70 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional specific healthcare equipment) include Telix Pharmaceuticals Limited (TLX), Establishment Labs Holdings Inc. (ESTA), Dentsply Sirona Inc. (XRAY), Cerus Corporation (CERS).